Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2008

View Archived Issues

Improved in vitro profile and therapeutic index with Pfizer's new bronchodilator UK-503590

Targeting the GPR4 receptor shows benefit in models of lung injury and COPD

Johnson & Johnson new LTA4H inhibitor reduces allergic airways inflammation in vivo

ST-2472 exhbits potent antipsychotic effects and good safety profile in vivo

Antitumor effects of chemotherapy enhanced by inhibition of N-cadherin

Novel mechanism for benzodiazepine receptor ligand PK-11195 identified

Medivir reports new therapeutic options for HCV infection in recent patent

Recent patents describe novel treatment alternatives for eye disorders

Recent patents disclose novel anti-HIV agents

Recent patents impart novel treatment options for cancer

DOR BioPharma withdraws E.U. MAA for orBec and plans phase III study

Allon completes dosing in phase II AL-208 cognitive impairment trial

FDA issues approvable letter for bazedoxifene in postmenopausal osteoporosis

GTx phase III toremifene trial continues after interim efficacy analysis

Novo Nordisk files for regulatory approval of liraglutide in the U.S. and Europe

ProStrakan grants exclusive license to JapanBridge for Sancuso in parts of Asia

Panobinostat active against poorly differentiated and anaplastic thyroid carcinoma cells

First patients enrolled in switch trial of oral iclaprim

Synthetic Blood International obtains exclusive license to VCU discoveries

Draxis Health acquisition approved by shareholders

First MS therapeutic from Novartis approved for launch in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...